Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Low-level light treatment ameliorates immune thrombocytopenia

These adverse effects of anti-CD41 antibody were all mitigated by LLLT to varying degrees, owing to its ability to enhance mitochondrial biogenesis and activity in megakaryocytes and preserve mitochondrial functions in platelets in the presence of the antibody.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied whether whole-body near infrared light therapy at 830 nm, given 30 minutes a day for a few consecutive days, could alleviate immune thrombocytopenia in mice. In two passive mouse models induced by an anti-CD41 antibody, they report that the treatment raised the lowest platelet counts and restored tail bleeding time, and they link this to improved mitochondrial function in megakaryocytes and platelets. The findings come from animal experiments.

Who or what was studied
Mice in two passive immune thrombocytopenia models induced by anti-CD41 antibody
Wavelengths
830 nm
Limits stated in the abstract
The study was conducted in mice using passive antibody-induced models, so its relevance to human immune thrombocytopenia is not established by the abstract.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Immune thrombocytopenia (ITP) is an immune-mediated acquired bleeding disorder characterized by abnormally low platelet counts. We reported here the ability of low-level light treatment (LLLT) to alleviate ITP in mice. The treatment is based on noninvasive whole body illumination 30 min a day for a few consecutive days by near infrared light (830 nm) transmitted by an array of light-emitting diodes (LEDs). LLLT significantly lifted the nadir of platelet counts and restored tail bleeding time when applied to two passive ITP models induced by anti-CD41 antibody. The anti-platelet antibody hindered megakaryocyte differentiation from the progenitors, impaired proplatelet and platelet formation, and induced apoptosis of platelets. These adverse effects of anti-CD41 antibody were all mitigated by LLLT to varying degrees, owing to its ability to enhance mitochondrial biogenesis and activity in megakaryocytes and preserve mitochondrial functions in platelets in the presence of the antibody. The observations argue not only for contribution of mitochondrial stress to the pathology of ITP, but also clinical potentials of LLLT as a safe, simple, and cost-effective modality of ITP.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
830 nm

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Low-level laser therapy. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies